CD44 and ovarian cancer: On another front, Mclean et al. identified the presence of cancer-associated MSCs, determined by CD44, CD73, and CD90 expressions, in ovarian cancer tissues and malignant ascites and explored the mutual relationship between MSCs and ovarian cancer stem cells [71].